Chromocell Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $6,862,284.
Profit Margin
| 2020 | 199.93K | -660.58K | -330.4% |
|---|---|---|---|
| 2023 | 0 | -7.38M |
CHRO Income Statement (2020 – 2023)
| 2023 | 2020 | |
|---|---|---|
Revenue | ||
Revenue | 0 | 199.93K |
Cost of revenue | 2.57M | 138.58K |
Gross profit | -2.57M | 61.34K |
Operating exp. | ||
Research and development | 2.57M | 138.58K |
Selling and marketing | 0 | 0 |
Total operating expenses | 6.86M | 1.55M |
Operating income | -6.86M | -1.35M |
Other income (expenses), net | -518.50K | 693.28K |
Income before tax | -7.38M | -660.58K |
Income tax expense | 0 | -1.35M |
Net income | -7.38M | -660.58K |
Earnings per share | ||
Basic EPS | -1.28 | -0.11 |
Diluted EPS | -1.28 | -0.11 |
| Data source |